Pediatric Scientist Development Program

儿科科学家发展计划

基本信息

  • 批准号:
    10220089
  • 负责人:
  • 金额:
    $ 140.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-12-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT This renewal application seeks NICHD support for 5 first-year and 5 second-year positions in the Pediatric Scientist Development Program (PSDP), a career development pathway for pediatric fellows from which 192 physician-scientists have graduated since 1987. The objectives of the program remain unchanged since its inception: (a) to recruit pediatric fellows whose outstanding potential for a successful investigative career can be developed in an intensively mentored setting and (b) to expand the pipeline of superbly trained pediatric physician-scientists, who will catalyze cutting-edge discoveries in child health and lead the pediatric departments of the future. Unique aspects of the PSDP include its North American scope for recruitment of fellows and mentors, its intensive focus on career development during fellowship, its supra-institutional governance under the aegis of the Association of Medical School Pediatric Department Chairs (AMSPDC), its emphasis on research environments outside departments of pediatrics, and its approach to mentoring that encompasses research mentors, PSDP advisory committees, and pediatric department chairs. Advisory Committees include a Steering Committee, which sets programmatic policy; a Selection Committee to interview PSDP candidates; and an independent Program Evaluation Committee measures the program’s effectiveness in ensuring fellows’ success. A centerpiece of the PSDP is the annual career development curriculum that convenes PSDP fellows, advisory committees, and all US and Canadian pediatric department chairs at the AMSPDC meeting. PSDP graduates have served as PIs on 335 NIH RPGs, of which 53% are currently active. Based on total awards of NIH RPGs with PSDP graduates are PIs, the return on NICHD investment is 8.8 fold. Innovations for 2017-2021 include a) leveraging NICHD funding by incorporating departmental support for up to 5 third-year fellows who will be appointed as instructors with 75-80% protected research time and b) expanding our career development curriculum with adult-learning educational modules that emphasize the fellow-to-faculty transition and team science, presented on site at AMSPDC and through web-based case-based studies. The PSDP has implemented a comprehensive strategy to expand the boundaries of child health research, to develop the research careers of rigorously trained pediatric physician-scientists, and to produce the next generation of investigative leaders in pediatrics.
项目摘要/摘要 此更新申请寻求NICHD支持5第一年和5第二年的职位, 儿科科学家发展计划(PSDP),儿科研究员的职业发展途径 自1987年以来,已有192名医学科学家毕业。该计划的目标仍然是 自成立以来一直保持不变:(a)招募儿科研究员,他们具有杰出的潜力, 成功的调查职业生涯可以在一个密集的指导环境中发展,(B)扩大 训练有素的儿科医生科学家的管道,谁将催化尖端的发现 在儿童健康方面的贡献,并领导未来的儿科部门。 私营部门发展方案的独特之处包括在北美征聘研究员和导师, 它在研究金期间对职业发展的高度重视, 在医学院儿科系主任协会(AMSPDC)的支持下, 关于儿科系外的研究环境,及其指导方法, 包括研究导师、PSDP咨询委员会和儿科系主任。 咨询委员会包括一个指导委员会,负责制定方案政策; 委员会面试PSDP候选人;和一个独立的方案评估委员会 衡量该计划在确保研究员成功方面的有效性。PSDP的核心是 每年的职业发展课程,召集PSDP研究员,咨询委员会,和所有美国 和加拿大儿科系主任在AMSPDC会议。PSDP毕业生曾担任 335个NIH RPG的PI,其中53%目前正在使用。基于NIH RPG的总奖励, PSDP毕业生是PI,NICHD投资回报率为8.8倍。 2017-2021年的创新包括a)通过纳入部门支持来利用NICHD资金 最多5名三年级研究员,他们将被任命为导师,75-80%的研究时间受到保护 和B)扩大我们的职业发展课程与成人学习教育模块, 强调研究员到教师的过渡和团队科学,在AMSPDC现场和通过 基于网络的案例研究。私营部门发展计划实施了一项全面战略, 儿童健康研究的界限,发展经过严格培训的儿科医生的研究事业, 医生科学家,并产生下一代的儿科研究领导者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(4)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sallie R. Permar其他文献

Neonatal Cytomegalovirus Infection: Advocacy, Legislation, and Changing Practice
新生儿巨细胞病毒感染:倡导、立法和实践的改变
  • DOI:
    10.1016/j.clp.2024.10.008
  • 发表时间:
    2025-03-01
  • 期刊:
  • 影响因子:
    2.400
  • 作者:
    Ashley Stark;Chelsea M. Crooks;Sallie R. Permar;Kristin Elizabeth Dew Weimer
  • 通讯作者:
    Kristin Elizabeth Dew Weimer
Maternal immune protection against infectious diseases
针对传染病的母体免疫保护
  • DOI:
    10.1016/j.chom.2022.04.007
  • 发表时间:
    2022-05-11
  • 期刊:
  • 影响因子:
    18.700
  • 作者:
    Stephanie N. Langel;Maria Blasi;Sallie R. Permar
  • 通讯作者:
    Sallie R. Permar
Breast milk delivery of an engineered dimeric IgA protects neonates against rotavirus
工程化二聚体免疫球蛋白 A 的母乳递送可保护新生儿免受轮状病毒感染
  • DOI:
    10.1016/j.mucimm.2025.01.002
  • 发表时间:
    2025-04-01
  • 期刊:
  • 影响因子:
    7.600
  • 作者:
    Stephanie N. Langel;Claire E. Otero;Justin T. Steppe;Caitlin A. Williams;Tatiana Travieso;Jerry Chang;Helen Webster;Lauren E. Williamson;James E. Crowe;Harry B. Greenberg;Huali Wu;Christoph P. Hornik;Katayoun Mansouri;Robert J. Edwards;Victoria Stalls;Priyamvada Acharya;Maria Blasi;Sallie R. Permar
  • 通讯作者:
    Sallie R. Permar
Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health
用于解决影响全球健康的传染病的纳米材料疫苗策略的进展
  • DOI:
    10.1038/s41565-020-0739-9
  • 发表时间:
    2020-08-17
  • 期刊:
  • 影响因子:
    34.900
  • 作者:
    Chelsea N. Fries;Elizabeth J. Curvino;Jui-Lin Chen;Sallie R. Permar;Genevieve G. Fouda;Joel H. Collier
  • 通讯作者:
    Joel H. Collier

Sallie R. Permar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sallie R. Permar', 18)}}的其他基金

Identifying and modeling immune correlates of protection against congenital CMV transmission after primary maternal infection
原发性母体感染后预防先天性巨细胞病毒传播的免疫相关性的识别和建模
  • 批准号:
    10677439
  • 财政年份:
    2023
  • 资助金额:
    $ 140.96万
  • 项目类别:
Pediatric Scientist Development Program
儿科科学家发展计划
  • 批准号:
    10619351
  • 财政年份:
    2022
  • 资助金额:
    $ 140.96万
  • 项目类别:
Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission
母体血浆广泛中和抗体的逃逸是艾滋病毒母婴传播的机制
  • 批准号:
    10327003
  • 财政年份:
    2021
  • 资助金额:
    $ 140.96万
  • 项目类别:
Pediatric Scientist Development Program
儿科科学家发展计划
  • 批准号:
    10349771
  • 财政年份:
    2020
  • 资助金额:
    $ 140.96万
  • 项目类别:
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
SARS-CoV-2 稳定预灌注 Spike 蛋白疫苗在幼年恒河猴中的免疫原性和功效
  • 批准号:
    10223633
  • 财政年份:
    2020
  • 资助金额:
    $ 140.96万
  • 项目类别:
Project-003
项目-003
  • 批准号:
    10461206
  • 财政年份:
    2019
  • 资助金额:
    $ 140.96万
  • 项目类别:
Core-001
核心001
  • 批准号:
    10461201
  • 财政年份:
    2019
  • 资助金额:
    $ 140.96万
  • 项目类别:
Project-003
项目-003
  • 批准号:
    10441007
  • 财政年份:
    2019
  • 资助金额:
    $ 140.96万
  • 项目类别:
Core-004
核心004
  • 批准号:
    10441005
  • 财政年份:
    2019
  • 资助金额:
    $ 140.96万
  • 项目类别:
Project 1: Immune correlates of cCMV
项目 1:cCMV 的免疫相关因素
  • 批准号:
    10215784
  • 财政年份:
    2019
  • 资助金额:
    $ 140.96万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 140.96万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 140.96万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 140.96万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 140.96万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 140.96万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 140.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了